D. Lewis

发表

Investigational drug therapies for coeliac disease – where to from here?

E. Newnham, J. Haridy, D. Lewis, 2018, Expert opinion on investigational drugs.

Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C.

P. Gow, S. Bell, J. Lubel, 2018, Journal of hepatology.

Anaemia, iron‐related measurements and erythropoietin levels in untreated patients with active leprosy

T. Bothwell, R. Baynes, E. J. Schulz, 1992, Journal of internal medicine.

Haematological and iron-related measurements in active pulmonary tuberculosis.

W. Bezwoda, T. Bothwell, R. Baynes, 2009, Scandinavian journal of haematology.

Hepatology Clinical

P. Gow, I. Kronborg, S. Roberts, 2016, Journal of gastroenterology and hepatology.

Deferasirox-induced liver injury and Fanconi syndrome in a beta-thalassemia major male

D. Lewis, Rowena Brook, Tony He, 2020, BMJ Case Reports.

An X-traordinary stroke

G. Warne, M. Grossmann, D. Lewis, 2011, The Lancet.

Prevalence and predictors of indeterminate IFN-γ release assays for latent TB at liver transplant assessment

P. Gow, I. Kronborg, S. Roberts, 2016 .

A long-term clinical review of patients with oesophageal pain.

J. Rhodes, G. Swift, D. Lewis, 1991, The Quarterly journal of medicine.

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis

D. V. van Langenberg, D. Lewis, A. Vasudevan, 2023, Biomedicines.

FKBP51 levels negatively correlate with Depressive symptoms in Chronic Hepatitis C

M. Saling, I. Everall, D. Liew, 2020 .

Testing for coeliac disease.

E. Newnham, J. Haridy, D. Lewis, 2017, Australian prescriber.